What is Equiscript?
Equiscript operates at the intersection of pharmaceutical logistics and community health advocacy. By partnering exclusively with 340B Covered Entities, including not-for-profit community health centers and hospitals, the company provides a high-touch home delivery pharmacy model. This approach ensures that patients receive personalized attention while maintaining strict alignment with their physicians' treatment plans. Beyond logistics, the Equiscript model is built on a social enterprise framework, where proceeds are systematically reinvested into the local communities served by their partner providers, thereby strengthening the financial sustainability of the safety net healthcare infrastructure.
How much funding has Equiscript raised?
Equiscript has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Equiscript
PPP
Public-Private Partnership
What's next for Equiscript?
With this major enterprise-level funding, Equiscript is poised to accelerate its operational footprint and enhance its technological infrastructure. The strategic focus will likely center on scaling its pharmacy management platform to accommodate a broader network of safety net providers, thereby increasing the reach of its patient-centric care model. As the regulatory landscape for 340B programs continues to evolve, Equiscript's ability to provide transparent, compliant, and community-focused pharmacy solutions will be a key driver of its long-term growth. The company is expected to leverage this capital to optimize its supply chain efficiency and deepen its integration with existing electronic health record systems, ensuring seamless coordination between providers and patients.
See full Equiscript company page
